Centessa Pharmaceuticals plc (CNTA) DCF Valuation

Centessa Pharmaceuticals plc (CNTA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Centessa Pharmaceuticals plc (CNTA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of Centessa Pharmaceuticals plc with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and examine how changes affect Centessa Pharmaceuticals plc (CNTA) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 6.9 6.9 6.9 6.9 6.9 6.9
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.9 -10.4 -379.2 -212.3 -166.1 4.1 4.1 4.1 4.1 4.1
EBITDA, % 100 100 100 100 -2423.26 60 60 60 60 60
Depreciation .0 .0 .0 .1 5.2 6.5 6.5 6.5 6.5 6.5
Depreciation, % 100 100 100 100 76.12 95.22 95.22 95.22 95.22 95.22
EBIT -4.9 -10.4 -379.2 -212.4 -171.3 4.1 4.1 4.1 4.1 4.1
EBIT, % 100 100 100 100 -2499.39 60 60 60 60 60
Total Cash 7.2 595.1 393.6 256.5 6.9 6.9 6.9 6.9 6.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 16.8 26.7 39.1
Account Receivables, % 100 100 100 100 571.25
Inventories 1.0 -17.8 -30.0 .0 5.5 5.5 5.5 5.5 5.5
Inventories, % 100 100 100 100 0.000014592149 80 80 80 80 80
Accounts Payable 1.0 7.3 13.8 11.8 6.9 6.9 6.9 6.9 6.9
Accounts Payable, % 100 100 100 100 172.41 100 100 100 100 100
Capital Expenditure .0 .0 -.2 -1.1 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -2.47 -0.49321 -0.49321 -0.49321 -0.49321 -0.49321
Tax Rate, % 14.22 14.22 14.22 14.22 14.22 14.22 14.22 14.22 14.22 14.22
EBITAT -5.2 -10.8 -379.3 -211.7 -146.9 4.0 4.0 4.0 4.0 4.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.2 -10.8 -371.2 -203.9 -186.3 32.3 10.5 10.5 10.5 10.5
WACC, % 11.44 11.44 11.44 11.43 11.35 11.42 11.42 11.42 11.42 11.42
PV UFCF
SUM PV UFCF 58.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 11
Terminal Value 114
Present Terminal Value 66
Enterprise Value 124
Net Debt -43
Equity Value 168
Diluted Shares Outstanding, MM 96
Equity Value Per Share 1.74

What You Will Receive

  • Comprehensive Financial Model: Centessa Pharmaceuticals’ actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Real-Time Calculations: Automatic updates provide immediate results as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed financial forecasts.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future forecasts for Centessa Pharmaceuticals plc (CNTA).
  • Adjustable Forecast Parameters: Modify highlighted fields such as discount rates, growth projections, and profit margins.
  • Automated Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear visualizations and summaries to present your valuation findings effectively.
  • Suitable for All Experience Levels: An intuitive layout designed for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the pre-configured Excel file containing Centessa Pharmaceuticals plc’s (CNTA) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC as per your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time for accurate insights.
  • Test Scenarios: Generate various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for Centessa Pharmaceuticals plc (CNTA)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Centessa Pharmaceuticals.
  • Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios for (CNTA).
  • In-Depth Analysis: Automatically computes Centessa’s intrinsic value and Net Present Value.
  • Preloaded Information: Access to historical and projected data for precise calculations.
  • Expert-Level Tool: Perfect for financial analysts, investors, and consultants focusing on (CNTA).

Who Should Use This Product?

  • Investors: Accurately assess Centessa Pharmaceuticals' fair value before making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Centessa Pharmaceuticals (CNTA).
  • Consultants: Efficiently customize the template for valuation reports tailored to Centessa Pharmaceuticals (CNTA) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies in the pharmaceutical sector.

What the Template Contains

  • Pre-Filled Data: Includes Centessa Pharmaceuticals plc's historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic computations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on tailored inputs.
  • Key Financial Ratios: Assess Centessa Pharmaceuticals plc's profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing key valuation outcomes.

No products were found matching.